https://doi.org/10.4081/monaldi.2022.2219
Comments on “Post severe COVID-19 infection lung damages study. The experience of early three months multidisciplinary follow-up” by De Michele et al.
Submitted: January 27, 2022
Accepted: February 18, 2022
Published: March 3, 2022
Accepted: February 18, 2022
Abstract Views: 1173
PDF: 271
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Dear Editor,
We read the original study by De Michele et al. titled “Post severe COVID-19 infection lung damages study. The experience of early three months multidisciplinary follow-up” with great interest...
De Michele L, Pierucci P, Giovannetti G, et al. Post severe COVID-19 infection lung damages study. The experience of early three months multidisciplinary follow-up. Monaldi Arch Chest Dis 2022;92:2142.
DOI: https://doi.org/10.4081/monaldi.2022.2142
Yildiz M, Yadigar S, Yildiz BŞ, et al. Evaluation of the relationship between COVID-19 pneumonia severity and pulmonary artery diameter measurement. Herz 2021;46:56-62.
DOI: https://doi.org/10.1007/s00059-020-05014-x
Wang M, Luo X, Wang L, et al. A Comparison of lung ultrasound and computed tomography in the diagnosis of patients with COVID-19: A systematic review and meta-analysis. Diagnostics (Basel) 2021;11:1351.
DOI: https://doi.org/10.3390/diagnostics11081351
How to Cite
Ruggeri, Paolo, Abhijit S. Nair, and Antonio Esquinas. 2022. “Comments on ‘Post Severe COVID-19 Infection Lung Damages Study. The Experience of Early Three Months Multidisciplinary Follow-up’ by De Michele Et Al”. Monaldi Archives for Chest Disease 92 (4). https://doi.org/10.4081/monaldi.2022.2219.
Copyright (c) 2022 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Velizar Hadzhiminev, Lybomir Paunov, Teodora Dimcheva, Angel Uchikov, Ivan Novakov, Spontaneous pneumothorax associated with COVID-19 pneumonia: a single-centre retrospective study , Monaldi Archives for Chest Disease: Vol. 92 No. 1 (2022)
- Anant Jain, Anusha Devarajan, Hussein Assallum, Ramin Malekan, Gregg Lanier, Oleg Epelbaum, Withdrawal: Characteristics of early pleural effusions after orthotopic heart transplantation: comparison with coronary artery bypass graft surgery , Monaldi Archives for Chest Disease: Early Access
- Andrea Lanza, Maurizio Sommariva, Sara Mariani, Gabriela Ferreyra, Giuliana Enrica Stagni, Valeria Tombini, Angela Oppizzi, Catia Pontiggia, Andrea Bellone, Prolonged non-invasive respiratory supports in a COVID-19 patient with severe acute hypoxemic respiratory failure , Monaldi Archives for Chest Disease: Vol. 92 No. 1 (2022)
- Cuneyt Tetikkurt, Halil Yanardag, Burcak Haluk Sayman, Muammer Bilir, Seza Tetikkurt, Seckin Bilgic, Bahar Kubat, Seyda Bilgin, Diagnostic utility of 68Ga-citrate and 18FDG PET/CT in sarcoidosis patients , Monaldi Archives for Chest Disease: Vol. 90 No. 4 (2020)
- Malay Sarkar, Irappa V. Madabhavi, Shailee Mehta, Swadeshkumar Mohanty, Use of flow volume curve to evaluate large airway obstruction , Monaldi Archives for Chest Disease: Vol. 92 No. 4 (2022)
- Biagio Polla, Roflumilast is effective in reducing COPD related exacerbations and improving CAT score , Monaldi Archives for Chest Disease: Vol. 79 No. 3-4 (2013): Pulmonary series - Supplement 1
- Gabriella Guarnieri, Roflumilast succeeds where traditional therapy fails: a case report , Monaldi Archives for Chest Disease: Vol. 79 No. 3-4 (2013): Pulmonary series - Supplement 1
- Riccardo Rovetta, Enrico Vizzardi, Antonio D’Aloia, Ivano Bonadei, Edoardo Sciatti, Marco Metra, An unusual case of myocardial infarction , Monaldi Archives for Chest Disease: Vol. 82 No. 2 (2014): Cardiac series
- Bruno Balbi, Roflumilast: the fourth Mousquetaire in COPD pharmacological treatment , Monaldi Archives for Chest Disease: Vol. 79 No. 3-4 (2013): Pulmonary series - Supplement 1
- Nicola Barbarito, A strange case of severe but fleeting hypoxemia in patient with COVID-19 infection: maybe virus-induced pulmonary Raynaud’s phenomenon? , Monaldi Archives for Chest Disease: Vol. 91 No. 2 (2021)
<< < 47 48 49 50 51 52 53 54 55 56 > >>
You may also start an advanced similarity search for this article.
